Chemodiversity in Freshwater and Terrestrial Cyanobacteria – A Source for Drug Discovery

Author(s): George E. Chlipala, Shunyan Mo, Jimmy Orjala

Journal Name: Current Drug Targets

Volume 12 , Issue 11 , 2011

Become EABM
Become Reviewer


Cyanobacteria are considered a promising source for new pharmaceutical lead compounds and a large number of chemically diverse and bioactive metabolites have been obtained from cyanobacteria over the last few decades. This review highlights the structural diversity of natural products from freshwater and terrestrial cyanobacteria. The review is divided into three areas: cytotoxic metabolites, protease inhibitors, and antimicrobial metabolites. The first section discusses the potent cytotoxins cryptophycin and tolytoxin. The second section covers protease inhibitors from freshwater and terrestrial cyanobacteria and is divided in five subsections according to structural class: aeruginosins, cyanopeptolins, microviridins, anabaenopeptins, and microginins. Structure activity relationships are discussed within each protease inhibitor class. The third section, antimicrobial metabolites from freshwater and terrestrial cyanobacteria, is divided by chemical class in three subsections: alkaloids, peptides and terpenoids. These examples emphasize the structural diversity and drug development potential of natural products from freshwater and terrestrial cyanobacteria.

Keywords: Cyanobacteria, cytotoxic, protease inhibitor, antibacterial, antifungal, protease inhibitors, chemodiversity, NRPS, PKS, genome sequence

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2011
Page: [1654 - 1673]
Pages: 20
DOI: 10.2174/138945011798109455
Price: $65

Article Metrics

PDF: 29